The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2%
Applications Of Live Cell Encapsulation Market:
Drug Delivery
Regenerative Medicine
Cell Transplantation
Probiotics
Research
By application, drug delivery are expected to be the largest contributor to the live cell encapsulation market
Cell encapsulation is undertaken for the manufacturing of tablets, capsules, and parenteral dosage forms for effective drug delivery. The growth of this segment includes the increasing adoption of cell encapsulation for drug delivery is mainly due to its procedural benefits (such as improved efficacy, reduced toxicity, and improved patient compliance & convenience).
Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218019375
